Sort
16,300 grants matching “fatty liver disease”
NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV
$371,250Keigo Machida · University Of Southern California · R01 · FY2019 · AA
Angiotensin: A Link Between Obesity and Hypertension
$371,250Lisa A Cassis · University Of Kentucky · R01 · FY2011 · HL
Angiotensin: A Link Between Obesity and Hypertension
$371,250Lisa A Cassis · University Of Kentucky · R01 · FY2009 · HL
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
$371,250Laurie D Deleve · University Of Southern California · R01 · FY2022 · DK
Innate Immunity, Cholesterol, and NASH Pathogenesis
$371,250Hugo R Rosen · University Of Southern California · R01 · FY2021 · DK
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
$371,250Laurie D Deleve · University Of Southern California · R01 · FY2021 · DK
NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV
$371,250Keigo Machida · University Of Southern California · R01 · FY2017 · AA
The Novel Approach of RNA Based Therapeutic Technologies
$371,250Ba-Bie Teng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · HL
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
$371,250Laurie D Deleve · University Of Southern California · R01 · FY2023 · DK
NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV
$371,250Keigo Machida · University Of Southern California · R01 · FY2021 · AA
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
$371,250Laurie D Deleve · University Of Southern California · R01 · FY2020 · DK
Innate Immunity, Cholesterol, and NASH Pathogenesis
$371,250Lucy Mary Golden · University Of Southern California · R01 · FY2022 · DK
Innate Immunity, Cholesterol, and NASH Pathogenesis
$371,250Lucy Mary Golden · University Of Southern California · R01 · FY2023 · DK
Mechanisms of ER stress - induced fatty liver
$371,250David Thomas Rutkowski · University Of Iowa · R01 · FY2010 · DK
The Novel Approach of RNA Based Therapeutic Technologies
$371,250Ba-Bie Teng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2010 · HL
NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV
$371,250Keigo Machida · University Of Southern California · R01 · FY2020 · AA
Angiotensin: A Link Between Obesity and Hypertension
$371,250Lisa A Cassis · University Of Kentucky · R01 · FY2010 · HL
Targeting Shc to reduce inflammation and fibrosis in the aging liver
$371,200Natalie J Torok · Palo Alto Veterans Instit For Research · R01 · FY2018 · AG
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$371,179Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Nuclear lipid-sensor in Type II Diabetic Neuropathy
$371,069Virginie Mansuy Aubert · Loyola University Chicago · R01 · FY2019 · DK
Nuclear lipid-sensor in Type II Diabetic Neuropathy
$371,069Virginie Mansuy Aubert · Loyola University Chicago · R01 · FY2020 · DK
Nuclear lipid-sensor in Type II Diabetic Neuropathy
$371,069Virginie Mansuy Aubert · Loyola University Chicago · R01 · FY2021 · DK
Nuclear lipid-sensor in Type II Diabetic Neuropathy
$371,069Virginie Mansuy Aubert · Loyola University Chicago · R01 · FY2022 · DK
Fatty Acid Desaturase 1 (FADS1) Variants and Non-alcoholic Fatty Liver Disease
$371,026Wanqing Liu · Wayne State University · R01 · FY2018 · DK
Investigation of the Molecular Mechanisms of Lipoprotein Lipase Inhibitors
$370,960Saskia Neher · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL